190 related articles for article (PubMed ID: 1620812)
1. Type II essential mixed cryoglobulinaemia: presentation, treatment and outcome in 13 patients.
Frankel AH; Singer DR; Winearls CG; Evans DJ; Rees AJ; Pusey CD
Q J Med; 1992 Feb; 82(298):101-24. PubMed ID: 1620812
[TBL] [Abstract][Full Text] [Related]
2. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
3. Cryoglobulinaemia: clinical features and response to treatment.
Singer DR; Venning MC; Lockwood CM; Pusey CD
Ann Med Interne (Paris); 1986; 137(3):251-3. PubMed ID: 3767196
[TBL] [Abstract][Full Text] [Related]
4. Heat-insoluble cryoglobulin in a patient with essential type II cryoglobulinemia and cryoglobulin-occlusive membranoproliferative glomerulonephritis: case report and literature review.
Meng QH; Chibbar R; Pearson D; Kappel J; Krahn J
Clin Chim Acta; 2009 Aug; 406(1-2):170-3. PubMed ID: 19463798
[TBL] [Abstract][Full Text] [Related]
5. [Familial membranoproliferative glomerulonephritis].
Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis.
Roccatello D; Baldovino S; Rossi D; Mansouri M; Naretto C; Gennaro M; Cavallo R; Alpa M; Costanzo P; Giachino O; Mazzucco G; Sena LM
Nephrol Dial Transplant; 2004 Dec; 19(12):3054-61. PubMed ID: 15494358
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus infection and cryoglobulinaemia.
Lunel F; Musset L
Forum (Genova); 1998; 8(1):95-103. PubMed ID: 9514994
[TBL] [Abstract][Full Text] [Related]
8. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy.
Mazzaro C; Franzin F; Tulissi P; Pussini E; Crovatto M; Carniello GS; Efremov DG; Burrone O; Santini G; Pozzato G
Cancer; 1996 Jun; 77(12):2604-13. PubMed ID: 8640712
[TBL] [Abstract][Full Text] [Related]
9. [Essential mixed cryoglobulinemia with kidney involvement].
Asamer H; Weiser G; Michlmayr G
Schweiz Med Wochenschr; 1975 Aug; 105(33):1057-61. PubMed ID: 1162315
[TBL] [Abstract][Full Text] [Related]
10. [Type II essential mixed cryoglobulinemia and renal disease. Hepatitis C virus association].
Almirall J; Amengual MJ; López T; Andreu X; Oristrell J; Sala M; Luelmo J; Dalmau B
Nefrologia; 2002; 22(6):531-9. PubMed ID: 12516286
[TBL] [Abstract][Full Text] [Related]
11. Vasculitis affecting the kidney: presentation, histopathology and long-term outcome.
Serra A; Cameron JS; Turner DR; Hartley B; Ogg CS; Neild GH; Williams DG; Taube D; Brown CB; Hicks JA
Q J Med; 1984; 53(210):181-207. PubMed ID: 6463195
[TBL] [Abstract][Full Text] [Related]
12. Renal involvement in monoclonal (type I) cryoglobulinemia: two cases associated with IgG3 kappa cryoglobulin.
Karras A; Noël LH; Droz D; Delansorne D; Saint-André JP; Aucouturier P; Alyanakian MA; Grünfeld JP; Lesavre P
Am J Kidney Dis; 2002 Nov; 40(5):1091-6. PubMed ID: 12407656
[TBL] [Abstract][Full Text] [Related]
13. [Essential mixed cryoglobulinemia and the kidneys].
Knotková V; Krystůfková O
Vnitr Lek; 1993 Jul; 39(7):706-13. PubMed ID: 8372467
[TBL] [Abstract][Full Text] [Related]
14. Case of membranoproliferative glomerulonephritis due to essential cryoglobulinemia without hepatitis C virus infection.
Okura T; Jotoku M; Miyoshi K; Enomoto D; Kurata M; Irita J; Nagao T; Ohtsuka T; Higaki J
Geriatr Gerontol Int; 2009 Mar; 9(1):92-6. PubMed ID: 19260986
[TBL] [Abstract][Full Text] [Related]
15. [IgG-IgM cryoglobulinemia with a purpura-arthralgia-nephritis syndrome].
Fontana A; Doll B; Joller H
Schweiz Med Wochenschr; 1982 Jan; 112(1):7-13. PubMed ID: 7058315
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis-B-associated glomerulonephritis: pathology, pathogenesis, and clinical course.
Venkataseshan VS; Lieberman K; Kim DU; Thung SN; Dikman S; D'Agati V; Susin M; Valderrama E; Gauthier B; Prakash A
Medicine (Baltimore); 1990 Jul; 69(4):200-16. PubMed ID: 2142748
[TBL] [Abstract][Full Text] [Related]
17. Renal lesions in essential mixed IgG-IgM cryoglobulinemia. Study of 48 cases.
Barbiano di Belgiojoso G; Bertoli S; Tarantino A; Colasanti G; Bosisio-Bestetti M; Ferrario F; Montagnino G; Banfi G; Bucci A; Surian M; Colussi G; Guerra L; Micoli G
Boll Ist Sieroter Milan; 1981; 60(4):316-27. PubMed ID: 7034747
[TBL] [Abstract][Full Text] [Related]
18. Cryoglobulinaemic membranoproliferative glomerulonephritis and hepatitis C virus infection.
Mazzaro C; Pozzato G; Zorat F; Panarello G; Silvestri F; Barillari G; Mazzoran L; Baracetti S; Crovatto M; Santini GF; Donadon V; Faccini L; Campanacci L
Ital J Gastroenterol Hepatol; 1999; 31(1):45-53. PubMed ID: 10091102
[TBL] [Abstract][Full Text] [Related]
19. Renal disease in essential mixed cryoglobulinaemia. Long-term follow-up of 44 patients.
Tarantino A; De Vecchi A; Montagnino G; Imbasciati E; Mihatsch MJ; Zollinger HU; Di Belgiojoso GB; Busnach G; Ponticelli C
Q J Med; 1981; 50(197):1-30. PubMed ID: 7267965
[TBL] [Abstract][Full Text] [Related]
20. Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma.
De Vita S; De Re V; Gasparotto D; Ballarè M; Pivetta B; Ferraccioli G; Pileri S; Boiocchi M; Monteverde A
Arthritis Rheum; 2000 Jan; 43(1):94-102. PubMed ID: 10643704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
